Skip to content
value.today

Trinity Biotech PLC vs VolitionRx Limited

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Trinity Biotech PLC is the larger company by market value: $8 M against $7 M for VolitionRx Limited, 1.1 times as much (market caps of Aug 1, 2026 for Trinity Biotech PLC and Oct 30, 2026 for VolitionRx Limited). Trinity Biotech PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • Trinity Biotech PLC had more revenue: $62 M in the year to December 2024 against $2 M for VolitionRx Limited in the year to December 2025.
  • Both made a net loss: $32 M for Trinity Biotech PLC and $23 M for VolitionRx Limited.
  • Trinity Biotech PLC keeps more of each dollar of sales: a net margin of -51.6% against -1350.3% for VolitionRx Limited.
  • VolitionRx Limited's revenue grew faster in its latest fiscal year: +40.6% against +8.3% for Trinity Biotech PLC.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0911822733642020202120222023202420252026Trinity Biotech PLC 36VolitionRx Limited 4

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B2016201720182019202020212022202320242025Trinity Biotech PLC $0BVolitionRx Limited $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureTrinity Biotech PLC
TRIB · #26,221 in the world
VolitionRx Limited
VNRX · #26,406 in the world
Profile
Country🇮🇪 Ireland🇺🇸 USA
SectorHealthcareHealthcare
IndustryDiagnostics and ResearchDiagnostics and Research
Founded—1998
Size
Market cap$8 M$7 M
Revenue$62 M$2 M
Net income$-32 M$-23 M▲ best
Valuation
Price to sales0.1×2.1×
Free cash flow yield-57.4%—
Profitability
Gross margin34.8%—
Operating margin-34.4%—
Net margin-51.6%—
Growth
Revenue growth8.3%40.6%▲ best
Revenue growth, 3 years a year-8.8%77.4%▲ best
Cash
Free cash flow margin-7.5%—
Altman Z-score zone—distress
Data as ofMarket cap Aug 2026; ratios FY2024Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Trinity Biotech PLC or VolitionRx Limited?

Trinity Biotech PLC is the larger company by market value: $8 M against $7 M for VolitionRx Limited, 1.1 times as much (market caps of Aug 1, 2026 for Trinity Biotech PLC and Oct 30, 2026 for VolitionRx Limited). Trinity Biotech PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Trinity Biotech PLC or VolitionRx Limited?

Trinity Biotech PLC had more revenue: $62 M in the year to December 2024 against $2 M for VolitionRx Limited in the year to December 2025. Both made a net loss: $32 M for Trinity Biotech PLC and $23 M for VolitionRx Limited.

Which is more profitable, Trinity Biotech PLC or VolitionRx Limited?

Trinity Biotech PLC keeps more of each dollar of sales: a net margin of -51.6% against -1350.3% for VolitionRx Limited.

Which is growing faster, Trinity Biotech PLC or VolitionRx Limited?

VolitionRx Limited's revenue grew faster in its latest fiscal year: +40.6% against +8.3% for Trinity Biotech PLC.

Sources#

Every figure on this page comes from these, with the date shown next to it.